Botulinum Toxin Formulation
作者： Wendy M. Blanda , Terrence J. Hunt , Michael R. Robinson , Scott M. Whitcup , Patrick M. Hughes
DOI:
关键词:
摘要: Botulinum neurotoxin formulated with a hyaluronic acid carrier increased residency time of the botulinum toxin at subdermal location and fewer induced complications or side effects.
lens.org参考文章(88)
Ryan A. Irvine, Eric R. First, Methods for enhancing skin treatments ,(2007)
Elias Hermida Ochoa, Use of mixture of sodium hyaluronate and chondroitin sulfate for use in products and therapies for cosmetic surgery ,(2005)
John Trogden, Robert Lyons, Scott Whitcup, James Chang, Triamcinolone compositions for intravitreal administration to treat ocular conditions ,(2006)
Adam Friedman, Jenny Kim, Robert Modlin, Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles ,(2007)
Stephen Donovan, Intravitreal botulinum toxin implant ,(2004)
Stephen Donovan, Controlled release botulinum toxin system ,(2003)
Stelios Tzannis, Steven Bitler, Sandra Ottensmann, David Taft, Wei-Guo Dai, Qiang Zheng, Adam Bell, Method for formulating a controlled-release pharmaceutical formulation ,(2008)
Albert G. Prescott, Dermal filler and method of using same ,(2008)
Gary E. Borodic, High-Potency Botulinum Toxin Formulations ,(2010)
Herbert Kerr Graham, Botulinum toxin for treating muscle contracture ,(2005)